Fundraise

Remedy Robotics raises $62M to push robotic stroke care remote

What's the deal? Remedy Robotics has raised $62 million in Series B funding led by DCVC to develop its AI-enabled endovascular surgery platform. New investors UC InvestmentsDealroom has a profile for this one. Try Dealroom →, Skip CapitalDealroom has a profile for this one. Try Dealroom →, and Australian pension fund HostplusDealroom has a profile for this one. Try Dealroom → joined, while existing backers Blackbird, Tony Fadell's Build CollectiveDealroom has a profile for this one. Try Dealroom →, Divergent CapitalDealroom has a profile for this one. Try Dealroom →, and KdT VenturesDealroom has a profile for this one. Try Dealroom → each doubled down.

What's the endgame? Remedy is finalising its N1 System, which uses machine learning to analyse preoperative imaging, simulate cases, and complete entire endovascular procedures robotically — on site, remotely, or autonomously. The company says it works with more than 100 hospitals and treats conditions that kill more people than all cancers combined.

What will the money do? The round funds a pivotal clinical trial with the University of California, work toward US Food and Drug Administration approval for neurovascular intervention, and deployment of prototype N1 Systems with partners including SVIN Mission Thrombectomy and the Australian Stroke Alliance.

Why now? In October 2025, Remedy reported completing the world's first fully remote neurointerventional procedures, carried out between two Toronto hospitals. "This funding will allow us to accelerate toward deployment of our N1 System," said chief executive officer and co-founder David Bell.

What could go wrong? The N1 remains investigational and is not cleared for commercial sale. The round backs a clinically and regulatorily unproven field, where approval and real-world adoption are far from guaranteed.

The signal: Institutional money is flowing into autonomous robotic stroke care. In August, the US agency ARPA-H committed up to $175.3 million over five years to teams including Siemens Healthineers and PhilipsDealroom has a profile for this one. Try Dealroom → to develop the technology — a sign of both the sector's momentum and the competition Remedy now faces.

Read more: dailyaibrief.com

Image credit: "NMCSD’s Radiology Department Prepares For Procedure" by NavyMedicine, public domain (Public Domain Mark 1.0)

More top stories